Novartis Says Profit May Drop on Entresto Spending, Gleevec

·

·

Novartis Says Profit May Drop on Entresto Spending, Gleevec

Novartis AG said profit may fall this year as the Swiss drugmaker increases spending on the heart medicine Entresto and faces declining sales of its best-selling cancer treatment Gleevec.
See Original Article

In Purging Foes, Erdogan Risks Weakening Turkey in Other Wars

Turkish President Recep Tayyip Erdogan's sweeping crackdown on opponents may leave him exposed in the face of other mounting threats.
See Original Article

North Korea Launches Ballistic Missiles Into Sea

South Korea accused North Korea of a “reckless provocation” Tuesday after the country test-fired three ballistic missiles, the latest in a series of
See Original Article

Soaring Temperatures Will Make It Too Hot to Work, UN Warns

Searing temperatures caused by climate change may cost global economies more than $2 trillion by 2030, restricting working hours in some of the
See Original Article

Where SMEs Use Accounting Tools Worse Than Spreadsheets

The dreaded spreadsheet: It's often cited by FinTech players as one of the most cumbersome and least efficient manual accounting tools.
See Original Article



Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.